Abbott Ups Vascular, Ophthalmic Focus With Two Acquisitions
This article was originally published in The Gray Sheet
Executive Summary
Abbott Laboratories announced July 15 it has entered into agreements to purchase stent manufacturer IDev Technologies and ophthalmic device company OptiMedica Corp. The acquisitions are intended to bolster the company’s medical device unit in the vascular and vision care businesses, respectively.